When Isabelle Rombauts is unexpectedly put in charge of the international family business LXR Pharma, she discovers that their drug for depression has potentially horrific side effects. The stakes in the business are so high that Isabelle’s attempts to uncover the truth are systematically thwarted. Ultimately, everything Isabelle holds dear comes into play at stake: her family, her son and – most importantly – her health and credibility.
Type: television series
Length: –
Production company: Topkapi Films
Year: 2025, funded by the regulation ‘Realisatie – Lang (2022)’.
Shot in: –
